Prescription Required
It is unsafe to consume alcohol with Imprax 0.25 mg/25 mg Tablet.
Imprax 0.25 mg/25 mg Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
Imprax 0.25 mg/25 mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Imprax 0.25 mg/25 mg Tablet may cause side effects which could affect your ability to drive.<BR>As Imprax 0.25 mg/25 mg Tablet may impair your alertness or cause drowsiness or blurred vision, and this may affect your ability to drive.
Imprax 0.25 mg/25 mg Tablet is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Imprax 0.25 mg/25 mg Tablet may not be needed in these patients. Please consult your doctor.
Imprax 0.25 mg/25 mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Imprax 0.25 mg/25 mg Tablet may be needed. Please consult your doctor.<BR>Regular monitoring of liver function tests is recommended while you are taking this medicine.
Imprax 0.25 mg/25 mg Tablet is a combination of two medicines: Alprazolam and imipramine which treat depression. Alprazolam is a benzodiazepine (BZD) which works by increasing the action of GABA, a chemical messenger which suppresses the abnormal and excessive activity of the nerve cells in the brain. Imipramine is a tricyclic antidepressant which increases the levels of chemical messengers in the brain that help in regulating the mood and treat depression.
Prescription Required
Simplify your healthcare journey with Indian Government's ABHA card. Get your card today!
Create ABHA